U.S.
Department of Health and Human
Services
Advisory Committee on Organ Transplantation
Recommendations 1–18
Following more than a year
of deliberations and meetings,
the Committee met on November
18-19, 2002, in Arlington,
Virginia, and unanimously agreed
on its first 18 consensus recommendations.
The first day of that meeting
was devoted by the Committee
to responding to Secretary
Thompson's specific request
to them that they look into
several concerns he had with
respect to the process of live
organ donation and transplantation — particularly
regarding the kidney, liver
and lung — so as to ensure
that the donation and transplantation
process would be as safe and
effective as possible, for
both the living organ donor
and the recipient of the donor's
organ.
ACOT believes that the implementation
of these first seven recommendations
will ensure the protection
of potential living donors
and simultaneously enhance
the effectiveness of living
donation and transplantation.
Recommendation 1:
That the following ethical
principles and informed consent
standards be implemented
for all living donors.
The Secretary's first request
was that ACOT consider the
desirability of national disclosure
standards. ACOT responded by
recommending a series of ethical
principles and elements of
informed consent that should
be implemented for all living
donors.
ACOT agrees upon a set of
Ethical Principles of Consent
to Being a Live Organ Donor,
which includes the view that
the person who gives consent
to becoming a live organ donor
must be:
- competent (possessing decision
making capacity)
- willing to donate
- free from coercion
- medically and psychosocially
suitable
- fully informed of the risks
and benefits as a donor and
- fully informed of the risks,
benefits, and alternative
treatment available to the
recipient.
Two related ethical principles
that ACOT endorses are:
- Equipoise; i.e., the benefits
to both the donor and the
recipient must outweigh the
risks associated with the
donation and transplantation
of the live donor organ;
and
- A clear statement that
the potential donor's participation
must be completely voluntary,
and may be withdrawn at any
time.
ACOT recommends that each
institution develop an informed
consent document that would
be understandable to all potential
donors. Such a document should
be accessible to people at
all educational levels, and
appropriate for the potential
donor's level of education.
Apart from the need to employ
specifically defined medical
terms, the document should
in most circumstances be written
for readers with no higher
than an 8th or 9th grade level
of education. If the potential
donor does not speak English,
there should be an independent
interpreter to facilitate understanding
in the patient's language.
Where appropriate, translations
of such a document and accompanying
materials should be made available.
ACOT further recommends that
the following Standards of
Disclosure: Elements of Informed
Consent be incorporated in
the informed consent document
given to the potential live
organ donor, with specific
descriptions that would ensure
the donor's awareness of:
- the purpose of the donation
- the evaluation process — including
interviews, examinations,
laboratory tests, and other
procedures — and the
possibility that the potential
donor may be found ineligible
to donate
- the donation surgical procedure
- the alternative procedures
or courses of treatment for
potential donor and recipient
- any procedures which are
or may be considered to be
experimental
- the immediate recovery
period and the anticipated
post-operative course of
care
- the foreseeable risks or
discomforts to the potential
donor
- the potential psychological
effects resulting from the
process of donation
- the reported national experience,
transplant center and surgeon-specific
statistics of donor outcomes,
including the possibility
that the donor may subsequently
experience organ failure
and/or disability or death
- the foreseeable risks,
discomforts, and survival
benefit to the potential
recipient
- the reported national experience
and transplant center statistics
of recipient outcomes, including
failure of the donated organ
and the possibility of recipient
death
- the fact that the potential
donor's participation is
voluntary, and may be withdrawn
at any time
- the fact that the potential
donor may derive a medical
benefit by having a previously
undetected health problem
diagnosed as a result of
the evaluation process
- the fact that the potential
donor undertakes risk and
derives no medical benefit
from the operative procedure
of donation
- the fact that unforeseen
future risks or medical uncertainties
may not be identifiable at
the time of donation
- the fact that the potential
donor may be reimbursed for
the personal expenses of
travel, housing, and lost
wages related to donation
- the prohibition against
the donor otherwise receiving
any valuable consideration
(including monetary or material
gain) for agreeing to be
a donor
- the fact that the donor's
existing health and disability
insurance may not cover the
potential long-term costs
and medical and psychological
consequences of donation
- the fact that the donor's
act of donation may adversely
affect the donor's future
eligibility for health, disability,
or life insurance
- additional informational
resources relating to live
organ donation (possibly
through the establishment
of a separate resources center,
as separately recommended)
- the fact that Government
approved agencies and contractors
will be able to obtain information
regarding the donor's health
for life and
- the principles of confidentiality,
clarifying that:
- communication between
the donor and the transplant
center will remain
confidential;
- a decision by the
potential donor not
to proceed with the
donation will only
be disclosed with the
consent of the potential
donor;
- the transplant center
will share the donor's
identity and other
medical information
with entities involved
in the procurement
and transplantation
of organs, as well
as registries that
are legally charged
to follow donor outcomes;
and
- confidentiality of
all patient information
will be maintained
in accord with applicable
laws and regulations.
ACOT also prepared two specific
informed consent documents
that embody these principles
and elements. The first relates
to the potential donor's initial
consent for evaluation as a
possible donor, Living
Liver Donor Initial Consent
for Evaluation (Appendix
1). The second deals with the
potential donor's informed
consent for surgery, Living
Liver Donor Informed Consent
for Surgery (Appendix 2).
ACOT recognizes that institutions
operating in different states
across the nation may have
different laws and needs that
will affect the precise wording
of the informed consent document(s)
they will use. For that reason,
these consent documents are
submitted as examples and possible
models only. Note as well that,
although the specific examples
are for living liver donation,
ACOT is recommending such forms
for all potential living organ
donors.
Moreover, ACOT does not believe
that these or any forms are
a substitute for in-person
communication between physicians
and other involved professionals
and the potential donor. These
forms should be viewed instead
as only the written evidence
of discussions leading to informed
consent based upon full disclosure.
Recommendation 2:
That each institution that
performs living donor transplantation
provide an independent donor
advocate to ensure that the
informed consent standards
and ethical principles described
above are applied to the
practice of all live organ
donor transplantation.
The Secretary's second request
was that ACOT consider the
desirability of an independent
donor advocate (or advocacy
team) to represent and advise
the donor so as to ensure that
the previously described elements
and ethical principles are
applied to the practice of
all live donor transplantation.
ACOT agrees with this principle
and herein provides detailed
recommendations as to how such
an independent donor advocate
should be established, as well
as the role and qualifications
of such an advocate.
ACOT recommends that each
transplant center identify
and provide to each potential
donor an independent and trained
patient advocate whose primary
obligation would be to help
donors understand the process,
the procedure and risks and
benefits of live organ donation;
and to protect and promote
the interests and well being
of the donor.
ACOT recognizes that there
is an acknowledged limitation
of objectivity and independence,
given the realities of the
processes that take place within
a transplant center among medical
colleagues who regularly interact
professionally; a modern, practicing
physician does not work in
a vacuum and cannot perform
in a way that is wholly apart
from other institutional staff.
Moreover, the donor advocate
should not be totally independent
of events affecting the recipient,
as there must be interaction
of the advocate with the transplant
surgeon of the recipient team.
However, the concept of preserving
a separate care physician for
the donor is underscored as
the reason to retain the word
independent in the identity
of the advocate.
Recommendation 3:
That a database of health
outcomes for all live donors
be established and funded
through and under the auspices
of the U.S. Department of
Health and Human Services.
The Secretary's third request
was that ACOT consider the
desirability of establishing
a living organ donor registry.
ACOT concurs with the Secretary's
suggestion and recommends that
a database of health outcomes
of all live donors be established
and further recommends that
the registry or database should
build upon existing smaller
databases, but believes that
a comprehensive national database
will be necessary to answer
the Secretary's desire that
all potential organ donors
be fully informed and aware
of the likely consequences
of their decisions.
The Secretary asked ACOT where
such a database should be established
and ACOT believes that only
the Department of Health and
Human Services has the authority
and resources to establish
such a registry. There are
valid competing arguments as
to what component of DHHS should
have primary responsibility
for funding and managing such
a registry, and ACOT therefore
offers no consensus suggestion
on this question, but ACOT
stands ready to assist the
Department in further deliberations
on this question.
ACOT further stands ready
to assist the Secretary in
suggesting information or data
elements (and the time periods
for the collection of such
data) that should be included
in such a registry, but it
was felt that further discussions
within the Department, and
with the OPTN, as well as with
the SRTR, would be necessary,
given ACOT's understanding
that the substantial cost implications
in establishing and maintaining
such a registry must be fully
explored.
In order to guide Departmental
deliberations on those questions,
ACOT responds to the Secretary's
request for its opinion on
how the information collected
should be used. ACOT believes
that the primary purpose of
such a registry should be to
enable the medical community
to define accurately the donor
risks and benefits of live
organ transplantation so as
to give potential donors an
accurate risk assessment.
Recommendation 4:
That serious consideration
be given to the establishment
of a separate resource center
for living donors and their
families.
ACOT recommends advancing
the information and resources
available to living donors
and their families through
the implementation of detailed
consent forms, the creation
of independent donor advocates
and the establishment of a
living donor registry. To similar
effect, ACOT recommends the
establishment of a separate
office, a resource center,
for potential living donors,
those who choose to donate,
as well as their families.
The primary function of such
a resource center would be
to ensure that each potential
donor receives a complete and
current set of information
about living organ donation.
An existing model for such
a resource center is in place
at the OPTN, which has both
a person to contact for information,
and a web site with information
specific to the needs of transplant
candidates and recipients.
The resource center could either
be located under the aegis
of the OPTN or the living donor
registry. Such a distinct resource
center would have the benefit
of being clearly distinguished
as separate and apart from
the transplant team and hospital.
Until such time as such an
independent resource center
is established, ACOT recommends
that transplant centers should
give consideration to providing
such a resource center on their
own, again with the purpose
of ensuring that each potential
donor receives a complete and
current set of information
about living organ donation.
Recommendation 5:
That the present preference
in OPTN allocation policy — given
to prior living organ donors
who subsequently need a kidney — be
extended so that any living
organ donor would be given
preference as a candidate
for any organ transplant,
should one become needed.
This recommendation states
that there should be a preference
accorded to the living organ
donor. The point value or other
means of assigning such a preference
is left to the OPTN.
Recommendation 6:
That the requirements for
HLA typing of liver transplant
recipients and/or living
liver donors should be deleted.
This testing may, however,
be appropriate for some donors
and recipients and in such
cases should be compensated
by Medicaid, Medicare or private
insurers as appropriate, when
specifically ordered, as for
all other appropriate laboratory
tests.
Recommendation 7:
That a process be established
that would verify the qualifications
of a center to perform living
donor liver or lung transplantation.
ACOT believes that a process
needs to be established that
would verify the qualifications
of a center to perform living
donor liver or lung transplantation.
ACOT believes that the process
for performing living kidney
transplantation is sufficiently
mature and established that
no further verification processes
are required. ACOT believes
that, owing to the relative
newness of the procedures,
as well as the inherent intricacies
of the operations, that centers
performing and seeking to perform
living donor liver and living
donor lung transplantation
each require further review
and verification within the
medical community.
The purpose of such a verification
process would be to give patients
an increased level of confidence
in the institutions performing
such operations, and to provide
a guide for centers seeking
to enter this field.
Although the Secretary's recent
letters to the Committee have
focused on living donation,
his overall charge to the Committee
has been much broader, and
ACOT has responded to that
charge by promulgating an additional
series of recommendations not
specific to living donation.
The second day of the ACOT
meeting was devoted by the
Committee to issues affecting
equitable access to transplantation,
and those relating to deceased
or cadaveric donors.
ACOT believes that the implementation
of the following two recommendations,
which relate to access to transplantation,
will especially benefit minority
populations.
Recommendation 8:
That specific methods be
employed to increase the
education and awareness of
patients at dialysis centers
as to transplant options
available to them.
Available information indicates
that too many patients at dialysis
centers are unaware of the
transplant options available
to them. Too many of these
patients are members of minority
groups. Given the cost of sustained
dialysis treatment, both to
patients and to the Centers
for Medicare and Medicaid Services,
as compared to the cost of
transplantation, this would
also be cost-effective as well
as life-saving.
In order to assure the accuracy
of this assessment, ACOT recommends
that procedural methodologies
be developed to evaluate dialysis
patient access and referral
for organ transplant, as well
as an accurate cost/benefit
analysis, using existing data
and/or new sources of data.
ACOT further recommends that,
as soon as possible, a health
education program be implemented,
and/or that an educational
coordinator be placed on site
at individual dialysis centers
so as to provide patients with
adequate education about transplant
options available to them.
This would be a reinforcement
of the implementation of existing
regulations stipulating that
dialysis patients be educated
and evaluated by personnel
from the transplant center
concerning this therapeutic
option.
Recommendation 9:
That research be conducted
into the causes of existing
disparities in organ transplant
rates and outcomes, with
the goal of eliminating those
disparities.
The fact of such disparities,
particularly with regard to
kidney transplantation rates,
appears to be undisputed, and
data developed by the SRTR
for ACOT highlights this issue.
HRSA, NIH and other DHHS agencies
are presently committed to
research aimed at ending such
disparities with respect to
health care delivery in other
areas, and research should
be undertaken to establish
whether any separate reasons
may exist for such disparities
within the transplantation
area, and, if so, how they
may be eliminated.
ACOT believes that the implementation
of the following nine recommendations,
which primarily relate to increasing
the supply of deceased donor
organs, will ultimately, and
in some cases very quickly,
mean many more additional organs
becoming available to potential
recipients.
Recommendation 10:
That legislative strategies
be adopted that will encourage
medical examiners and coroners
not to withhold life-saving
organs and tissues from qualified
organ procurement organizations.
Studies indicate that coroners
and medical examiners across
the United States are not uniform
in their approach to making
organs available to organ procurement
organizations, and that many
unnecessarily withhold from
retrieval organs that could
be used for transplantation.
Indeed, it is estimated that
if all states followed the
example of Texas, which has
enacted a law containing a
provision similar to the one
below, then 700-1,000 additional
organs would be made additionally
available each year.
The Secretary is specifically
encouraged to use his good
standing with the National
Governor's Association, the
National Association of State
Legislatures, the Uniform Commissioners
of State Laws, and/or with
individual states to seek the
following change:
To amend the Uniform Anatomical
Gift Act (UAGA) to add a new
subsection at the end of section
4, as follows:
(d) If the medical examiner
is considering withholding
one or more organs or tissues
of a potential donor for any
reason, the medical examiner
shall be present during the
removal of the organs or tissue.
In such case, the medical examiner
may request a biopsy of those
organs or tissue, or deny their
removal. If the medical examiner
denies removal of any organ
or tissue, the medical examiner
shall explain in writing the
reasons for the denial and
shall provide the explanation
to the qualified organ procurement
organization.
In the alternative, the Secretary
is asked to encourage individual
states to adopt state laws
to the same or similar effect.
Recommendation 11:
That the secretary of HHS,
in concert with the Secretary
of Education, should recommend
to states that organ and
tissue donation be included
in core curriculum standards
for public education as well
as in the curricula of professional
schools, including schools
of education, schools of
medicine, schools of nursing,
schools of law, schools of
public health, schools of
social work, and pharmacy
schools.
The Secretary of HHS, in collaboration
with the Secretary of Education,
should identify relevant core
curriculum standards, and survey
those courses and curricula
that presently include education
as to organ and tissue donation,
with a view to promoting a
model standard that can be
broadly employed in public
education. This would, at a
minimum, include all high schools.
In addition, hospitals should
establish ongoing basic introductory
(new hire) programs, focused
on organ and tissue donation
that would be similar to CPR
certification and recertification,
and might in fact be accommodated
within the same new hire program.
Efforts should also be made
to ensure that organ and tissue
donation be a part of the professional
educational curricula at all
professional schools related
to health. Law schools are
included because of the relevance
of such issues to courses in
elder law, estate planning,
and health law.
Recommendation 12:
That in order to ensure best
practices, organ procurement
organizations and the OPTN
be encouraged to develop,
evaluate, and support the
implementation of improved
management protocols of potential
donors.
This recommendation builds
upon those made at previous
conferences held by various
transplantation related organizations,
as well as work performed under
contract to the Department.
A novel and improved standard
of titrated care for heart
and lung donors has been established
and ACOT believes that it should
be more generally implemented.
It is known as the Critical
Pathway for the Organ Donor (Appendix
3, Adobe Acrobat — get
the free
Reader). Similar improved
standards of management and
care should be developed to
optimize the potential recovery
of other organs.
Recommendation 13:
That in order to ensure best
practices at hospitals and
organ procurement organizations,
the following measure should
be added to the CMS conditions
of participation: each hospital
with more than 100 beds should
identify an advocate for
organ and tissue donation
from within the hospital
clinical staff.
Such a designated advocate
for organ and tissue donation
would be responsible for assuring
that the facility is in compliance
with the Conditions of Participation
as well as any other policies
that pertain to organ and tissue
donation. In addition, this
designated advocate's responsibilities
would include assuring that
efforts are made to promote
donation in the local community.
(Given varying hospital management
structures, such an advocate
may not always be a member
of the clinical staff; what
is essential, however, is that
the advocate have the institutional
authority to effect change.)
Recommendation 14:
That in order to ensure best
practices at hospitals and
organ procurement organizations,
the following measure should
be added to the CMS conditions
of participation: Each hospital
should establish, in conjunction
with its OPO, policies and
procedures to manage and
maximize organ retrieval
from donors without a heartbeat.
Such donation is often referred
to as donation after cardiac
death, and such donors are
variously referred to as donors
without a heartbeat or non-heart-beating
donors, These policies and
procedures will need to be
developed in collaboration
with the OPTN, the transplant
centers and AOPO.
Recommendation 15:
That the following measure
be added to the CMS conditions
of participation: Hospitals
shall notify organ procurement
organizations prior to the
withdrawal of life support
to a patient, so as to determine
that patient's potential
for organ donation. If it
is determined that the patient
is a potential donor, the
OPO shall reimburse the hospital
for appropriate costs related
to maintaining that patient
as a potential donor.
Recommendation 16:
That the regulatory framework
provided by CMS for transplant
center and Organ Procurement
Organization certification
should be based on principles
of continuous quality improvement.
Subsequent failure to meet
performance standards established
under such principles should
trigger quality improvement
processes under the supervision
of HRSA.
The relevant committee of
the OPTN is encouraged to develop
baseline measures/principles
to guide the process of continuous
quality improvement, a part
of which process is the development
of baseline measures. The quality
improvement process envisioned
by ACOT might resemble one
that is presently utilized
in some hospitals/facilities,
and known as FOCUS-PDCA (Appendix
4).
Recommendation 17:
That all hospitals, particularly
those with more than one
hundred beds, be strongly
encouraged by CMS and AHRQ
to implement policies such
that the failure to identify
a potential organ donor and/or
refer such a potential donor
to the organ procurement
organization in a timely
manner be considered a serious
medical error. Such events
should be investigated and
reviewed by hospitals in
a manner similar to that
for other major adverse healthcare
events.
This measure could be added
to the sort of physician profile
which most facilities currently
employ. (See example
physician profile (Appendix
5, Adobe Acrobat — get
the free
Reader). ACOT expects that
this Recommendation will have
its greatest impact at those
hospitals with trauma centers,
as well as those with residency
programs and/or academic affiliations.
Recommendation 18:
That the Joint Commission
on Accreditation of Healthcare
Organizations (JCAHO) strengthen
its accreditation provisions
regarding organ donation,
including consideration of
treating as a sentinel event
the failure of hospitals
to identify a potential donor
and/or refer a donor to the
relevant Organ Procurement
Organization in a timely
manner. Similar review should
be considered by the National
Committee on Quality Assurance
(NCQA).
JCAHO presently defines and
identifies a sentinel event
as: An unexpected occurrence
involving death or serious
physical or psychological injury,
or the risk thereof. Serious
injury specifically includes
loss of limb or function. The
phrase, "or the risk thereof" includes
any process variation for which
a recurrence would carry a
significant chance of a serious
adverse outcome. Such events
are called "sentinel" because
they signal the need for immediate
investigation and response.
Failing to identify or refer
a potential donor in a timely
manner carries the serious
risk of that donor's organs
not being made available to
a potential recipient. Given
the shortage of organs and
the fact of so many potential
recipients dying while awaiting
the possibility of transplantation,
such a failure would appear
to fall within the JCAHO definition
of a sentinel event.
Monitoring hospitals for compliance
with organ donation standards
should become an integral part
of the JCAHO hospital survey
process. In addition to examination
of the standard, the hospital
JCAHO survey should include
the OPO referral records which
are submitted back to the hospital,
as well as the supporting documentation
of corrective measures or follow-up.
There should be a compliance
benchmark set (e.g., 90-100%),
with anything below that benchmark
requiring a gap analysis.
Go to: Consensus
Recommendations 19-28 (May
2003)
Go to: Consensus
Recommendations 29-35 (November
2003)
Go to: Consensus
Recommendations 36-41 (November
2004)
Go to: Consensus
Recommendation 42 (May
2005)
Back to: ACOT
Recommendations
Back to: Research,
Best Practices, and Legislation
|